Five more drugs to be recalled from Taiwan! 2 drugs for hypertension use 4.34 million capsules per year-Food and Drug Stop-Free Health Net

[Reportero Lin Huiqin / Taipei Report]There is another drug to be withdrawn from Taiwan! The Food and Drug Administration of the Ministry of Health, Welfare and Welfare declared today that five drugs are involved in an uncertain future supply and other related factors, including drugs for the treatment of high blood pressure, AIDS, antivirals, glaucoma and allergic rhinitis. . They are expected to withdraw from Taiwan later this year and early next year. The market; among them, 2 drugs for hypertension used more than 4.34 million health insurances a year.

Pan Xiangying, Jian Ren Jizheng of the FDA Drug Team, said current antihypertensive drugs “Jieshirui 10g” and “Puxining Sustaining Tablet 10g” are expected; the AIDS antiviral drug “Nuo Yiya 100 mg film-coated tablets”; glaucoma medication “Levus Instant Eyedrop”; Allergic rhinitis drug “Bikechuan Dry Powder Inhaler 200MCG / DOSE” is expected to be withdrawn from the Taiwan market later this year and early next year.

Read on …

According to the analysis and drug use statistics on the website of the National Health Insurance Agency, taking as an example last year, the reported annual consumption of “Jieshirui 10 gong” is approximately 2.522 million and “Poxining 10 gong “is approximately 1.82 million. Capsules, “Noeia 100mg Film-Coated Tablets” about 171,000 tablets, “Lishi Instant Eye Drops” about 338 bottles, and “Bikechuan for Inhalation Dry Powder 200MCG / DOSE” 2921 bottles.

Pan Xiangying emphasized that the link between Wuhan pneumonia (novel coronavirus disease, COVID-19) this year, China, which manufactures the largest amount of API in the world, once suspended production, and India once banned exports. This has somewhat led to a shortage of drugs, but it has gradually stabilized. However, in the past, due to national requirements to update PICS / GMP (Western Good Manufacturing Practice for Medicines), up to a dozen medicines were withdrawn from Taiwan within one year.

Pan Xiangying pointed out that these five drugs are relatively common drugs, and there are at least two or three alternative drugs for each drug, so people do not have to worry too much about the lack of available drugs.

Regarding future supply, AstraZeneca, a pharmaceutical company that produces “Jiecirui 10 gms” and “Poxining 10 gms”, said that these two drugs are mainly due to the transfer of sales rights, Factors such as the management of drug certificates are uncertain on the future situation of the supply, for which the competent authority is proactively notified in accordance with the law to protect the rights and interests of patients.

Regarding AbbVie medications, he noted that Noea film-coated tablets cannot be used alone and must be combined with other medications. For this reason, in recent years priority has been given to the compound three in one or four in one. Without affecting the rights and interests of patients, he has decided to stop selling. Reduction.

☆ Health news is not lost, follow the fan page for likes.

☆ For more important medical news, visit FreeHealth.com.

No need to draw, no need to grab, watch the news with the app now, make sure you win prizes every day, download the app and follow me to see the activity method.